EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Major depressive disorder and the risk of irritable bowel syndrome: A Mendelian randomization study

Ruiming Zhu, Nan Zhang, He Zhu, Fudong Li, Hong Xu

Molecular Genetics & Genomic Medicine · 2024-03 · 12 (3)

DOI: 10.1002/mgg3.2413 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 04.03.2024. Verfasst von Ruiming Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy, The First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Major Depressive Disorder, Irritable Bowel Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jilin Province Development and Reform Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between major depressive disorder (MDD) and irritable bowel syndrome (IBS) has been found in observational research; however, the causative relationship between MDD and IBS remains uncertain. Using the two‐sample Mendelian randomization (MR) approach, we attempted to examine the causal effect of MDD on IBS.

Methods

Independent genetic variants for MDD identified by Howard et al. based on a genome‐wide meta‐analysis were selected for this study. Gene‐Outcome associations for IBS were gathered from UK Biobank and FinnGen databases. The MR analysis included inverse variance weighted (IVW), MR‐Egger regression, weighted median, weighted mode, and MR‐PRESSO sensitivity analyses.

Results

FinnGen database subjected to inverse variance weighted (IVW) analysis revealed that MDD may be a risk factor for the development of IBS (OR = 1.356, 95% CI: 1.125–1.632, p = 0.0013). The same finding was reached in UK Biobank for IVW (OR = 1.011, 95% CI: 1.006–1.015, p = 3.18 × 10 −7 ), MR‐Egger progression (OR = 1.030, 95% CI: 1.008–1.051, p = 0.007), and weighted median (OR = 1.011, 95% CI: 1.005–1.016, p = 0.0001).

Conclusion

Our findings supported a causal relationship between MDD and IBS, which may have implications for the clinical management of IBS in individuals with MDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderIrritable Bowel SyndromeHumansMendelian Randomization AnalysisDatabases, FactualRisk Factors

Stichwörter der Autor:innen

Mendelian randomizationirritable bowel syndromemajor depressive disorder

Autor:innen und Institutionen

  • Department of Endoscopy, The First Hospital of Jilin University, Changchun, Jilin, China.

Förderung

  • Jilin Province Development and Reform Commission

Zitieren

APA

Zhu, R., Zhang, N., Zhu, H., Li, F., & Xu, H. (2024). Major depressive disorder and the risk of irritable bowel syndrome: A Mendelian randomization study. Molecular Genetics & Genomic Medicine, 12(3). https://doi.org/10.1002/mgg3.2413

Vancouver

Zhu R, Zhang N, Zhu H, Li F, Xu H. Major depressive disorder and the risk of irritable bowel syndrome: A Mendelian randomization study. Molecular Genetics & Genomic Medicine. 2024;12(3). doi:10.1002/mgg3.2413

BibTeX
@article{Zhu2024,
  author = {Zhu, Ruiming and Zhang, Nan and Zhu, He and Li, Fudong and Xu, Hong},
  title = {Major depressive disorder and the risk of irritable bowel syndrome: A Mendelian randomization study},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  volume = {12},
  number = {3},
  doi = {10.1002/mgg3.2413}
}
Kostenlos starten →